HEADLINES
NEWS
PAGE THREE
COMMENTARY
BUSINESS
LIFE
ACTION
GLOBAL GOALS
SNAPS
DYARYO TIRADA
MORE

HEADLINES
NEWS
PAGE THREE
COMMENTARY
BUSINESS
LIFE
ACTION
GLOBAL GOALS
SNAPS
DYARYO TIRADA
MORE

AstraZeneca

Study confirms AstraZeneca jab’s higher risk of very rare clot

Study confirms AstraZeneca jab’s higher risk of very rare clot

Agence France-Presse

27 Oct 2022

2 min read

Follow Us

NEWS⌄
COMMENTARY⌄
- EDITORIAL
- OPINION
BUSINESS⌄
LIFE⌄

2000

Powered by Quintype

Daily Tribune

tribune.net.ph